H3 Biomedicine Inc. clinical trials

A subsidiary of Eisai Co., Ltd.

The registry lists 1 studies whose lead sponsor is H3 Biomedicine Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2023.

Status

Completed: 1

Phase

Phase 1: 1

Where

Singapore: 1
Canada: 1
United States: 1
Belgium: 1
Spain: 1
Korea, Republic of: 1

Registry sponsor names on this page

H3 Biomedicine Inc.1 study

Something wrong with this grouping? Tell us on the Eisai Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Eisai Co., Ltd. studies →

Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular CarcinomaCompletedNCT02834780Phase 1
Sponsor listed in the registry: H3 Biomedicine Inc.